BIND-014
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for BIND-014, covering 2016-02-09 to 2016-04-18. Get the full timeline:
Most recent: Clinical Trial Update: A Study of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension) as Second-line Therapy for Patients With KRAS Positive or Squamous Cell Non-Small Cell Lung Cancer [Phase 2]